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For almost two years now, the Department of Radiation Oncology at IUPUI has been 
working with IUCF to develop the ability to use protons to treat cancer.' In the past 
year, significant progress has been made, with several studies now completed. Since April 
of 1991, we have had beam for seven runs. During those runs work was done on: beam 
spreading, range modulation, a preliminary investigation into beam cont aminatioq2 raster 
scanning techniques and proton radiography,3 dose monitoring, detector calibrations, beam 
profile monitors, and in vivo measurements of the beam relative biological effectiveness 
(RBE).4 Furthermore, a great deal of work has been done on the final designs for the 
proton therapy facility.' 
While the motivation for proton radiation therapy has been discussed before,' a brief 
reminder is in order. Proton radiation therapy has several advantages over the conven- 
tional radiation therapy techniques (x-rays and electrons) that are commonly available 
at hospitals. The first advantage is illustrated by comparing depth-dose curves for 60Co 
x-rays, 20 MeV electrons, and 200 MeV protons (see Fig. 1). Two advantages are readily 
apparent: 1) for a fixed dose at the tumor, the protons generally give a lower dose to 
healthy tissue in front of the tumor, 2) the sharp cut-off of the Bragg peak ensures that 
healthy tissue beyond the tumor is not damaged by protons. Another advantage comes 
from the fact that the multiple scattering for protons is small enough that a very sharp 
lateral dose profile can be maintained, even when treating tumors deep in tissue. This 
reduces the radiation delivered to tissue next to the tumor, while providing the maximum 
dose at the tumor site. These advantages have been known for some time,6 but the cost 
and/or availability of a suitable proton beam (energy 2 200 MeV) have limited the number 
of facilities established. 
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Figure 1. Depth-dose curves for 60Co x-rays (dots), 20 MeV electrons (dashes), and 
200 MeV protons (solid). 
We have constructed and tested three lateral beam spreading systems, based on the 
Harvard d e ~ i ~ n . ~ ~ ~  These systems use two scattering foils and concentric annuli to allow 
us to produce flat beam profiles with diameters from 8.5 to 18.6 cm. Table I shows the 
measured characteristics for each system. Figure 2 shows an example of a lateral dose 
distribution. While these results are satisfactory, we have noted two significant difficulties 
with systems of this type. 
The first problem is that the concentric annuli type beam spreading systems are 
very sensitive to alignment and beam position errors. The annuli axis must lie along the 
treatment axis, and the beam must be centered on the annulus system, as well as collinear. 
Relatively small deviations can produce large asymmetries in the dose profile. We are 
planning two projects to address this problem. We are presently constructing a prototype 
of a multi-wire beam profile monitor. These monitors will give us precise information 
about the position of the incident beam, and ultimately can be used in a steering loop to 
maintain a centered, collinear beam. Additionally, we have constructed a second type of 
lateral beam spreading system, which uses contoured scattering foils.8 This system should 
be less sensitive to the beam alignment, a hypothesis which we will test soon. 
Table I: Beam Profile Results 
Field size is the distance between the 95% points on a beam profile ionization curve, 
normalized to the central axis value. 
Flatness is the variation in ionization profile, measured over the central 80% of the field. 
Symmetry is the deviation from 1 of the maximum ratio of ionization readings (averaged 
over 1 cm) for symmetric points in the flat (central 80%) region of an ionization profile. 
Penumbra is the distance between the 90% and 10% ionization points. 
Table 11: Depth Modulation Results 
Modulation is the extent of the depth plateau. 
L 
Modulation 
(cm) 
4.3 
7.5 
19.0 
Surface dose is the ratio of the ionization measured near the surface to that measured 
at the peak. 
Flatness is defined similar to that for the profile. 
The dist a1 falloff is the distance from the 90% ionization level to the 10% ionization level 
at the distal edge. 
Surface 
Dose (%) 
59 
71 
95 
Flatness 
(%) 
4.6 
2.8 
3.3 
Dist a1 
Falloff (cm) 
.67 
.65 
.70 
Figure 2. Proton dose vs. horizontal and vertical position (given in em). 
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Figure 9. SEM output current vs. beam current for SEM #1 (circles) and SEM #2 
(squares). Lines represent fits to data. 
The second drawback of the lateral beam spreading systems (which is common to both 
the annulus and the contoured scatter types), is that each beam spreading system works 
only for the beam energy for which it was designed. We are just beginning to research 
ways these systems could be modified to reduce their energy dependence. 
In addition to the lateral spreading of the beam, we have developed range modulatorsg 
to produce a depth plateau, often referred to as a spread out Bragg peak (SOBP). At this 
point, we have constructed and tested three range modulators whose measured character- 
istics are given in Table 11. While quite satisfactory for the energy for which they were 
designed (200 MeV, in this case), the range modulators also have the drawback that their 
design is energy dependent. 
In order to deliver accurate doses, reliable non-destructive beam diagnostics are nec- 
essary. We have recently constructed two secondary electron monitors (SEMs). Our beam 
tests of the SEMs measured the response of each device for different beam currents, dif- 
ferent beam energies, and different bias polarities. The two new SEMs proved to be quite 
satisfactory, showing a linear response over a wide range of beam currents. Figure 3 shows 
the results from the calibration of each SEM against a Faraday cup over a range of beam 
currents . 
In addition to the SEMs, two segmented ion chambers will be used to monitor both 
the integrated charge, and the field symmetry. Each chamber provides 4 signals: up, 
down, left, and right. We have established the response of each segment so that on-line 
comparisons of the different segments will yield information about the field symmetry. 
Our first in vivo measurements determined the relative biological effectiveness (RBE) 
of the proton beam. Four different biological end-points (LDloo, spleen cell cellularity, 
lymphocyte proliferation, and frequency of chromatin fragment formation) extracted from 
total body irradiation of healthy mice yielded an RBE value (compared to Co) of 1.27 
0.04. More recently we investigated the RBE in a fractionated treatment of cancer cells 
in mice. Eighteen mice with cancerous tumors on their thighs received local irradiations 
of protons while the same number received similar treatment with 250 keV x-rays. Each 
mouse received a dose of 600 cGy three times a week for 2 weeks. We have yet to extract 
a value for the RBE from this work. 
The present effort is directed toward automated dose delivery and patient positioning. 
A real time computer system will be used to observe the output of all beam monitor devices. 
This system will stop treatment when the proper dose has been reached, or if the beam 
fails to meet certain criteria. Eventually, feedback loops will be added so that the system 
will try to correct problems with the beam (such as a beam position error) based on the 
information provided by the various beam monitors. We have acquired a chair that will 
allow a patient to be positioned for treatment of head and neck tumors. Additional systems 
which we have acquired for patient alignment include: a laser alignment system, a light 
field port verification system, and an x-ray port verification system. Our expectations are 
that the entire system will be completed and ready for patient treatment by the end of 
this calendar year. 
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